Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2016 (2016), Article ID 5194239, 13 pages
http://dx.doi.org/10.1155/2016/5194239
Research Article

Superoxide Dismutase 1 Nanozyme for Treatment of Eye Inflammation

1Chemistry Faculty, M.V. Lomonosov Moscow State University, Moscow 119991, Russia
2Helmholtz Institute for Eye Disease, Moscow 105062, Russia
3UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7362, USA
4Macquarie University, Sydney, NSW 2109, Australia
5Research Institute for Molecular Medicine, I.M. Sechenov First Moscow State Medical University, Moscow 119992, Russia
6Pirogov Russian National Research Medical University, Moscow 117997, Russia

Received 9 April 2015; Revised 6 August 2015; Accepted 12 August 2015

Academic Editor: Felipe Simon

Copyright © 2016 Olga A. Kost et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Miserocchi, G. Fogliato, G. Modorati, and F. Bandello, “Review on the worldwide epidemiology of uveitis,” European Journal of Ophthalmology, vol. 23, no. 5, pp. 705–717, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Bansal, V. Gupta, and A. Gupta, “Current approach in the diagnosis and management of panuveitis,” Indian Journal of Ophthalmology, vol. 58, no. 1, pp. 45–54, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Khairallah, M. Accorinti, C. Muccioli, R. Kahloun, and J. H. Kempen, “Epidemiology of Behçet disease,” Ocular Immunology and Inflammation, vol. 20, no. 5, pp. 324–335, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Uyama, “Uveitis in sarcoidosis,” Int Ophthalmol Clin, vol. 42, no. 1, pp. 143–150, 2002. View at Publisher · View at Google Scholar
  5. E. T. Cunningham Jr. and J. D. Wender, “Practical approach to the use of corticosteroids in patients with uveitis,” Canadian Journal of Ophthalmology, vol. 45, no. 4, pp. 352–358, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Kruh and C. S. Foster, “The philosophy of treatment of uveitis: past, present and future,” Developments in Ophthalmology, vol. 51, pp. 1–6, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Kulkarni, “Review: uveitis and immunosuppressive drugs,” Journal of Ocular Pharmacology and Therapeutics, vol. 17, no. 2, pp. 181–187, 2001. View at Publisher · View at Google Scholar
  8. N. A. Rao, A. J. Calandra, A. Sevanian, B. Bowe, J. M. Delmage, and G. E. Marak Jr., “Modulation of lens-induced uveitis by superoxide dismutase,” Ophthalmic Research, vol. 18, no. 1, pp. 41–46, 1986. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Yamada, H. Shichi, T. Yuasa, Y. Tanouchi, and Y. Mimura, “Superoxide in ocular inflammation: human and experimental uveitis,” Journal of Free Radicals in Biology and Medicine, vol. 2, no. 2, pp. 111–117, 1986. View at Publisher · View at Google Scholar · View at Scopus
  10. V. S. Nirankari, S. D. Varma, V. Lakhanpal, and R. D. Richards, “Superoxide radical scavenging agents in treatment of alkali burns. An experimental study,” Archives of Ophthalmology, vol. 99, no. 5, pp. 886–887, 1981. View at Publisher · View at Google Scholar · View at Scopus
  11. J. L. Alio, M. J. Ayala, M. E. Mulet, A. Artola, J. M. Ruiz, and J. Bellot, “Antioxidant therapy in the treatment of experimental acute corneal inflammation,” Ophthalmic Research, vol. 27, no. 3, pp. 136–143, 1995. View at Google Scholar · View at Scopus
  12. Y. de Kozak, J. P. Nordman, J.-P. Faure, N. A. Rao, and G. E. Marak Jr., “Effect of antioxidant enzymes on experimental uveitis in rats,” Ophthalmic Research, vol. 21, no. 3, pp. 230–234, 1989. View at Publisher · View at Google Scholar · View at Scopus
  13. N. A. Rao, A. Sevanian, M. A. S. Fernandez et al., “Role of oxygen radicals in experimental allergic uveitis,” Investigative Ophthalmology and Visual Science, vol. 28, no. 5, pp. 886–892, 1987. View at Google Scholar · View at Scopus
  14. N. B. Chesnokova, B. B. Neroev, O. V. Beznos et al., “Oxidative stress in uveitis and its correction with superoxide dismutase antioxidative enzyme (experimental study),” Vestnik Oftalmologii, vol. 130, pp. 30–34, 2014. View at Google Scholar
  15. M. R. Prausnitz and J. S. Noonan, “Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye,” Journal of Pharmaceutical Sciences, vol. 87, no. 12, pp. 1479–1488, 1998. View at Publisher · View at Google Scholar · View at Scopus
  16. R. C. Nagarwal, S. Kant, P. N. Singh, P. Maiti, and J. K. Pandit, “Polymeric nanoparticulate system: a potential approach for ocular drug delivery,” Journal of Controlled Release, vol. 136, no. 1, pp. 2–13, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. M. A. Zarbin, C. Montemagno, J. F. Leary, and R. Ritch, “Nanotechnology in ophthalmology,” Canadian Journal of Ophthalmology, vol. 45, no. 5, pp. 457–476, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. E. V. Batrakova, S. Li, A. D. Reynolds et al., “A macrophage-nanozyme delivery system for Parkinson's disease,” Bioconjugate Chemistry, vol. 18, no. 5, pp. 1498–1506, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. E. G. Rosenbaugh, J. W. Roat, L. Gao et al., “The attenuation of central angiotensin II-dependent pressor response and intra-neuronal signaling by intracarotid injection of nanoformulated copper/zinc superoxide dismutase,” Biomaterials, vol. 31, no. 19, pp. 5218–5226, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Zhao, M. J. Haney, N. L. Klyachko et al., “Polyelectrolyte complex optimization for macrophage delivery of redox enzyme nanoparticles,” Nanomedicine, vol. 6, no. 1, pp. 25–42, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. N. L. Klyachko, D. S. Manickam, A. M. Brynskikh et al., “Cross-linked antioxidant nanozymes for improved delivery to CNS,” Nanomedicine: Nanotechnology, Biology, and Medicine, vol. 8, no. 1, pp. 119–129, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. D. S. Manickam, A. M. Brynskikh, J. L. Kopanic et al., “Well-defined cross-linked antioxidant nanozymes for treatment of ischemic brain injury,” Journal of Controlled Release, vol. 162, no. 3, pp. 636–645, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. V. A. Kostyuk and A. I. Potapovich, “Superoxide-driven oxidation of quercetin and a simple sensitive assay for determination of superoxide dismutase,” Biochemistry International, vol. 19, no. 5, pp. 1117–1124, 1989. View at Google Scholar · View at Scopus
  24. V. V. Neroev, G. A. Davydova, and T. S. Perova, “Model of immunogenic uveitis in rabbits,” Bulletin of Experimental Biology and Medicine, vol. 142, no. 5, pp. 649–650, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. V. N. Alekseev, E. B. Martynova, and I. V. Churilova, Method for treating primary open angle glaucoma, RU2144343 (C1), 2000.
  26. J. Bieth, P. Metais, and J. Warter, “Detection and determination of alpha 2-macroglobulin trypsin activity in pleural fluids and ascites,” Enzyme, vol. 12, no. 1, pp. 13–24, 1971. View at Google Scholar · View at Scopus
  27. V. F. Nartikova and T. S. Paskhina, “A method for estimation of α1-antitrypsin and of α2-macroglobulin in human blood serum (plasma) in normal state and under some pathological conditions,” Voprosy Meditsinskoj Khimii, vol. 25, no. 4, pp. 494–499, 1979. View at Google Scholar · View at Scopus
  28. O. V. Gulidova, O. B. Lyubitskii, G. I. Klebanov, and N. B. Chesnokova, “Antioxidant activity of tear fluid in experimental alkali eye burns,” Bulletin of Experimental Biology and Medicine, vol. 128, no. 11, pp. 1155–1158, 1999. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Dong, B. Xie, J. Shen et al., “Oxidative stress promotes ocular neovascularization,” Journal of Cellular Physiology, vol. 219, no. 3, pp. 544–552, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. C.-B. Fang, D.-X. Zhou, S.-X. Zhan et al., “Amelioration of experimental autoimmune uveitis by leflunomide in Lewis rats,” PLoS ONE, vol. 8, no. 4, Article ID e62071, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. D. E. Panrucker and F. L. Lorscheider, “Synthesis of acute-phase α2-macroglobulin during inflammation and pregnancy,” Annals of the New York Academy of Sciences, vol. 417, pp. 117–124, 1983. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Kuribayashi, M. Tomizawa, T. Seita, K. Tagata, and S. Yamamoto, “Relationship between production of acute-phase proteins and strength of inflammatory stimulation in rats,” Laboratory Animals, vol. 45, no. 3, pp. 215–218, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Saraswathy and N. A. Rao, “Mitochondrial proteomics in experimental autoimmune uveitis oxidative stress,” Investigative Ophthalmology and Visual Science, vol. 50, no. 12, pp. 5559–5566, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. B. K. Singh, A. Kumar, I. Ahmad et al., “Oxidative stress in zinc-induced dopaminergic neurodegeneration: implications of superoxide dismutase and heme oxygenase-1,” Free Radical Research, vol. 45, no. 10, pp. 1207–1222, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. B. Halliwell, “Reactive oxygen species and the central nervous system,” Journal of Neurochemistry, vol. 59, no. 5, pp. 1609–1623, 1992. View at Publisher · View at Google Scholar · View at Scopus
  36. C. A. Papaharalambus and K. K. Griendling, “Basic mechanisms of oxidative stress and reactive oxygen species in cardiovascular injury,” Trends in Cardiovascular Medicine, vol. 17, no. 2, pp. 48–54, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. J. Lugrin, N. Rosenblatt-Velin, R. Parapanov, and L. Liaudet, “The role of oxidative stress during inflammatory processes,” Biological Chemistry, vol. 395, no. 2, pp. 203–230, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. K. Yasui and A. Baba, “Therapeutic potential of superoxide dismutase (SOD) for resolution of inflammation,” Inflammation Research, vol. 55, no. 9, pp. 359–363, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. I. V. Churilova, E. V. Zinov'ev, B. A. Paramonov, Y. I. Drozdova, V. O. Sidel'nikov, and V. Y. Chebotarev, “Effect of erysod (erythrocyte superoxide dismutase) on blood concentration of reactive oxygen species in patients with severe burns and burn shock,” Bulletin of Experimental Biology and Medicine, vol. 134, no. 5, pp. 454–456, 2002. View at Publisher · View at Google Scholar · View at Scopus
  40. Y. Mizushima, K. Hoshi, A. Yanagawa, and K. Takano, “Topical application of superoxide dismutase cream,” Drugs under Experimental and Clinical Research, vol. 17, no. 2, pp. 127–131, 1991. View at Google Scholar · View at Scopus
  41. K. Vorauer-Uhl, E. Fürnschlief, A. Wagner, B. Ferko, and H. Katinger, “Topically applied liposome encapsulated superoxide dismutase reduces postburn wound size and edema formation,” European Journal of Pharmaceutical Sciences, vol. 14, no. 1, pp. 63–67, 2001. View at Publisher · View at Google Scholar · View at Scopus
  42. M. K. Reddy, L. Wu, W. Kou, A. Ghorpade, and V. Labhasetwar, “Superoxide dismutase-loaded PLGA nanoparticles protect cultured human neurons under oxidative stress,” Applied Biochemistry and Biotechnology, vol. 151, no. 2-3, pp. 565–577, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. M. K. Reddy and V. Labhasetwar, “Nanoparticle-mediated delivery of superoxide dismutase to the brain: an effective strategy to reduce ischemia-reperfusion injury,” The FASEB Journal, vol. 23, no. 5, pp. 1384–1395, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. M. Hangaishi, H. Nakajima, J.-I. Taguchi et al., “Lecithinized Cu, Zn-superoxide dismutase limits the infarct size following ischemia-reperfusion injury in rat hearts in vivo,” Biochemical and Biophysical Research Communications, vol. 285, no. 5, pp. 1220–1225, 2001. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Giovagnoli, G. Luca, I. Casaburi et al., “Long-term delivery of superoxide dismutase and catalase entrapped in poly(lactide-co-glycolide) microspheres: in vitro effects on isolated neonatal porcine pancreatic cell clusters,” Journal of Controlled Release, vol. 107, no. 1, pp. 65–77, 2005. View at Publisher · View at Google Scholar · View at Scopus
  46. M. L. Corvo, J. C. S. Jorge, R. van't Hof, M. E. M. Cruz, D. J. A. Crommelin, and G. Storm, “Superoxide dismutase entrapped in long-circulating liposomes: formulation design and therapeutic activity in rat adjuvant arthritis,” Biochimica et Biophysica Acta—Biomembranes, vol. 1564, no. 1, pp. 227–236, 2002. View at Publisher · View at Google Scholar · View at Scopus
  47. T. M. Redmond, E. J. Duke, W. H. Coles, J. A. V. Simson, and R. K. Crouch, “Localization of corneal superoxide dismutase by biochemical and histocytochemical techniques,” Experimental Eye Research, vol. 38, no. 4, pp. 369–378, 1984. View at Publisher · View at Google Scholar · View at Scopus
  48. U. C. S. Yadav, N. M. Kalariya, and K. V. Ramana, “Emerging role of antioxidants in the protection of uveitis complications,” Current Medicinal Chemistry, vol. 18, no. 6, pp. 931–942, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. Y. Diebold and M. Calonge, “Applications of nanoparticles in ophthalmology,” Progress in Retinal and Eye Research, vol. 29, no. 6, pp. 596–609, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. S. Shimmura, R. Igarashi, H. Yaguchi, Y. Ohashi, J. Shimazaki, and K. Tsubota, “Lecithin-bound superoxide dismutase in the treatment of noninfectious corneal ulcers,” American Journal of Ophthalmology, vol. 135, no. 5, pp. 613–619, 2003. View at Publisher · View at Google Scholar · View at Scopus
  51. X. Yi, M. C. Zimmerman, R. Yang, J. Tong, S. Vinogradov, and A. V. Kabanov, “Pluronic-modified superoxide dismutase 1 attenuates angiotensin II-induced increase in intracellular superoxide in neurons,” Free Radical Biology and Medicine, vol. 49, no. 4, pp. 548–558, 2010. View at Publisher · View at Google Scholar · View at Scopus
  52. M. J. Haney, P. Suresh, Y. Zhao et al., “Blood-borne macrophage-neural cell interactions hitchhike on endosome networks for cell-based nanozyme brain delivery,” Nanomedicine, vol. 7, no. 6, pp. 815–833, 2012. View at Publisher · View at Google Scholar · View at Scopus
  53. Y. Zhao, M. J. Haney, V. Mahajan et al., “Active targeted macrophage-mediated delivery of catalase to affected brain regions in models of Parkinson's disease,” Journal of Nanomedicine & Nanotechnology, supplement 4, article 003, 2011. View at Publisher · View at Google Scholar
  54. Y. He, S.-B. Jia, W. Zhang, and J.-M. Shi, “New options for uveitis treatment,” International Journal of Ophthalmology, vol. 6, no. 5, pp. 702–707, 2013. View at Publisher · View at Google Scholar
  55. N. Haghjou, M. Soheilian, and M. J. Abdekhodaie, “Sustained release intraocular drug delivery devices for treatment of uveitis,” Journal of Ophthalmic and Vision Research, vol. 6, no. 4, pp. 317–319, 2011. View at Google Scholar · View at Scopus
  56. N. V. Saraiya and D. A. Goldstein, “Dexamethasone for ocular inflammation,” Expert Opinion on Pharmacotherapy, vol. 12, no. 7, pp. 1127–1131, 2011. View at Publisher · View at Google Scholar · View at Scopus
  57. D. S. Friedman, J. T. Holbrook, H. Ansari et al., “Risk of elevated intraocular pressure and glaucoma in patients with uveitis: results of the multicenter uveitis steroid treatment trial,” Ophthalmology, vol. 120, no. 8, pp. 1571–1579, 2013. View at Publisher · View at Google Scholar · View at Scopus